ADAR1 Partners LP 13D and 13G filings for Cellectar Biosciences, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-01-31 08:00 am Purchase | 2024-01-23 | 13G | Cellectar Biosciences, Inc. CLRB | ADAR1 Partners LP | 60,802 6.210% | 60,802 (New Position) | Filing |